Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.
Lucas
B Daniel
BD
Centers for Clinical Sciences Research, Charleston Area Medical Center Health Education and Research Institute, 3200 Mac-Corkle Avenue, S.E., Charleston, WV 25304-1200, USA. dan.lucas@camc.org
D003084:Colestipol / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use*; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D008148:Lovastatin; D003084:Colestipol